DeepMed Research

ANRS, Emerging Infectious Diseases

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C

Conditions: Exposure to Hepatitis C Virus

First Posted Date: 2016-07-11

Last Posted Date: 2017-04-10

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 550

Registration Number: NCT02826447

Locations: 🇪🇬
Ain Shams University Teaching Hospital, Cairo, Egypt

Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings

Phase 3

Completed

Conditions: HIV-1 Infection

Interventions: Drug: Dolutegravir 50 mg
Drug: Efavirenz 400 mg
Drug: Tenofovir disoproxil fumarate 300 mg / lamivudine 300 mg

First Posted Date: 2016-05-19

Last Posted Date: 2021-08-31

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 616

Registration Number: NCT02777229

Locations: 🇨🇲
Military Hospital, Yaoundé, Cameroon
🇨🇲
Hopital Central, Yaoundé, Cameroon
🇨🇲
Cité verte Hospital, Yaoundé, Cameroon

Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors

Phase 2

Completed

Conditions: Maternal-fetal Infection Transmission

Interventions: Drug: darunavir monotherapy

First Posted Date: 2016-04-14

Last Posted Date: 2021-08-06

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 91

Registration Number: NCT02738502

Locations: 🇫🇷
Hôpital Saint André, Bordeaux, France
🇫🇷
Hôpital Louis Mourier, Colombes, France
🇫🇷
Hôpital Bicêtre, Le Kremlin Bicêtre, France

and more 20 locations

CLEAC (Comparison of Late Versus Early Antiretroviral Therapy in HIV-infected Children)

Not Applicable

Conditions: HIV Infection

Interventions: Other: Blood draw

First Posted Date: 2016-02-05

Last Posted Date: 2019-01-18

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 80

Registration Number: NCT02674867

Locations: 🇫🇷
Hôpital Jean Verdier, Bondy, France
🇫🇷
Hôpital Louis Mourier, Colombes, France
🇫🇷
Centre Hospitalier Intercommunal, Créteil, France

and more 8 locations

Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir

Phase 2

Completed

Conditions: Hepatitis C

Interventions: Drug: Grazoprevir/Elbasvir
Drug: Sofosbuvir
Drug: Ribavirin

First Posted Date: 2016-01-06

Last Posted Date: 2017-06-29

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 26

Registration Number: NCT02647632

Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa

Not Applicable

Completed

Conditions: HIV Infection

Interventions: Other: HIV quarterly global care

First Posted Date: 2015-12-10

Last Posted Date: 2021-04-22

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 885

Registration Number: NCT02626286

Locations: 🇲🇱
Clinique des Halles, ARCAD-SIDA, Bamako, Mali
🇹🇬
Espoir vie Togo, Lome, Togo
🇧🇫
Centre Oasis, Association African Solidarité (AAS), Ouagadougou, Burkina Faso

and more 1 locations

Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS

Not Applicable

Conditions: Cryptococcal Meningitis

Interventions: Drug: Antiretroviral therapy
Drug: Fluconazole

First Posted Date: 2015-12-08

Last Posted Date: 2018-03-15

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 186

Registration Number: NCT02624453

Locations: 🇨🇲
Day Hospital of the Yaounde Central Hospital, Yaounde, Central Region, Cameroon

Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study

Not Applicable

Completed

Conditions: HIV-1 Infection

Interventions: Other: Health related quality of life and social and demographic informations
Other: Neurocognitive assessment
Radiation: cerebral images sub-study

First Posted Date: 2015-10-30

Last Posted Date: 2018-01-08

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 220

Registration Number: NCT02592174

Locations: 🇫🇷
Hôpital Michallon- Service des Maladies Infectieuses, Grenoble, France
🇫🇷
Hôpital Bretonneau - Service des Maladies Infectieuses, Tours, France
🇫🇷
Centre Hospitalier de Cannes - Service de Médecine Interne Oncologie, Cannes, France

and more 3 locations

Evaluation of an Innovative Tuberculosis Diagnostic Test

Conditions: Tuberculosis
HIV

First Posted Date: 2015-10-12

Last Posted Date: 2015-10-12

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 300

Registration Number: NCT02573623

Locations: 🇿🇲
Department of Paediatrics and Child Health, University Teaching Hospital.UNZA-SOM, Lusaka, Zambia

Feasibility of Interventions on People Who Inject Drugs in Vietnam

Completed

Conditions: Substance Abuse
Hepatitis Virus
HIV

First Posted Date: 2015-10-12

Last Posted Date: 2018-09-18

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 603

Registration Number: NCT02573948

Locations: 🇻🇳
Hai Phong Medical University, Hai Phong, Vietnam

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy